AZN vs USNA · P/E 28, $288.38B cap vs P/E 18, rev $473.5M
AstraZeneca PLC (AZN) versus USANA Health Sciences Inc (USNA) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
USANA Health Sciences Inc (USNA) is a packaged foods company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported USNA revenue for 2026-07-04 was $473.5M. Net income was -$13.9M. Revenue was up 89.2% from 2026-04-04 to 2026-07-04. USNA currently screens at market cap $610.3M and trailing P/E 18.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. USNA currently screens at market cap $610.3M and trailing P/E 18.0.
Not investment advice. Open the AZN and USNA stock pages for the full models.
Not investment advice.